Skip to Main Content

SAN FRANCISCO — Monday at the J.P. Morgan Healthcare Conference came and went without significant buyouts or deals, and so, biotech stocks fell.

The sector’s most closely followed stock index closed down 2%. Gene therapy developer Uniqure (QURE) — high on many investors’ takeout list — was among the sector’s biggest Monday losers. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!